PL3094338T3 - Oznaczenie i lek - Google Patents

Oznaczenie i lek

Info

Publication number
PL3094338T3
PL3094338T3 PL15701244.4T PL15701244T PL3094338T3 PL 3094338 T3 PL3094338 T3 PL 3094338T3 PL 15701244 T PL15701244 T PL 15701244T PL 3094338 T3 PL3094338 T3 PL 3094338T3
Authority
PL
Poland
Prior art keywords
medicament
assay
Prior art date
Application number
PL15701244.4T
Other languages
English (en)
Polish (pl)
Inventor
Nigel J. DIMMOCK
Andrew J. EASTON
Original Assignee
The University Of Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Warwick filed Critical The University Of Warwick
Publication of PL3094338T3 publication Critical patent/PL3094338T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • C12N7/045Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16132Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation
    • C12N2760/16162Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL15701244.4T 2014-01-16 2015-01-16 Oznaczenie i lek PL3094338T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1400752.0A GB2522615A (en) 2014-01-16 2014-01-16 Assay and medicament
PCT/GB2015/050094 WO2015107357A1 (en) 2014-01-16 2015-01-16 Assay and medicament

Publications (1)

Publication Number Publication Date
PL3094338T3 true PL3094338T3 (pl) 2022-08-08

Family

ID=50239057

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15701244.4T PL3094338T3 (pl) 2014-01-16 2015-01-16 Oznaczenie i lek

Country Status (8)

Country Link
US (3) US20160333321A1 (enExample)
EP (2) EP4085917A1 (enExample)
JP (1) JP6781045B2 (enExample)
DK (1) DK3094338T3 (enExample)
ES (1) ES2913063T3 (enExample)
GB (1) GB2522615A (enExample)
PL (1) PL3094338T3 (enExample)
WO (1) WO2015107357A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4046689A1 (en) * 2021-02-18 2022-08-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Influenza virus defective interfering particles for use in the prophylactic or therapeutic treatment of coronaviridae infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0408424D0 (en) * 2004-04-15 2004-05-19 Univ Warwick Viral assay
EP2272950A3 (en) * 2004-11-11 2011-07-20 Abbott Biologicals B.V. Defective influenza virus particles
GB2437799B (en) * 2006-05-24 2008-08-13 Univ Warwick Defective interfering virus
AU2007253033B2 (en) * 2006-05-24 2013-01-24 The University Of Warwick Defective interfering virus
GB0822672D0 (en) * 2008-12-12 2009-01-21 Univ Warwick Anti-viral protection with viruses containing a defective genome
US20130156733A1 (en) * 2011-12-20 2013-06-20 Philip I. Marcus Influenza virus populations, methods of use and methods of making thereof

Also Published As

Publication number Publication date
JP2017504331A (ja) 2017-02-09
US11339374B2 (en) 2022-05-24
US20220325251A1 (en) 2022-10-13
DK3094338T3 (da) 2022-05-23
WO2015107357A1 (en) 2015-07-23
EP4085917A1 (en) 2022-11-09
GB2522615A (en) 2015-08-05
JP6781045B2 (ja) 2020-11-04
EP3094338B1 (en) 2022-04-13
GB201400752D0 (en) 2014-03-05
US20160333321A1 (en) 2016-11-17
EP3094338A1 (en) 2016-11-23
US20200231939A1 (en) 2020-07-23
ES2913063T3 (es) 2022-05-31

Similar Documents

Publication Publication Date Title
IL252532A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical use
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
GB201519858D0 (en) Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
IL247014A0 (en) 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use
HUE044571T2 (hu) Módosított ciklopentapeptidek és alkalmazásaik
GB201401617D0 (en) Novel combination and use
HUE052575T2 (hu) Új kombináció és alkalmazás
ZA201703976B (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof
TWI563001B (en) Disintegrin variants and pharmaceutical uses thereof
GB201404372D0 (en) Assay and treatment
ZA201701492B (en) Pyrazolothiazole compound and medicine
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
PT3129398T (pt) Novos agentes médicos e usos dos mesmos
GB201418809D0 (en) Therapeutic agents and uses thereof
EP3204003A4 (en) Selenosugars and therapeutic uses thereof
PL3094338T3 (pl) Oznaczenie i lek
GB201617761D0 (en) Medicament and assay
GB201617726D0 (en) Medicament and assay
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201404728D0 (en) Disc-over incorporating disc-heads and disc-earning
PT2923578T (pt) Método para a produção de um produto alimentar